Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
13.64
+0.02 (0.15%)
Sep 1, 2026, 10:05 AM EDT - Market open
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $10.88 billion as of September 1, 2026. Its market cap has decreased by -38.19% in one year.
Market Cap
10.88B
Enterprise Value
10.21B
1-Year Change
-38.19%
Ranking
Category
Stock Price
$13.64
ChartMarket Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $10.88B, an increase of 9,043.95%. That is a compound annual growth rate of 48.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 10.88B | -16.43% |
| Dec 31, 2025 | 13.02B | -1.06% |
| Dec 31, 2024 | 13.16B | 619.43% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
| Mar 5, 2015 | 119.00M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Corcept Therapeutics | 12.31B |
| Arrowhead Pharmaceuticals | 11.99B |
| Halozyme Therapeutics | 11.96B |
| Bio-Techne | 11.35B |
| ABIVAX Société Anonyme | 10.58B |
| Axsome Therapeutics | 10.42B |
| Krystal Biotech | 10.40B |
| Apogee Therapeutics | 10.18B |